Insulin and Glucagon Hormone Levels in Women with Diabetes and Toxoplasmosis in Tikrit: A Comparative Study of Co-infection and Control Groups

Abstract

The current study included measuring the level of the hormone insulin and some other hormonal variables for 210 samples of women who were referred to the outpatient clinics for a period from October 2021 to March 2022. A group with diabetes and toxoplasmosis, a group with diabetes, and a control group. The results of the statistical analysis demonstrated that there was no significant difference in insulin hormone levels between women with toxoplasmosis and the control group (9.42 ± 3.38). However, a significant decrease in insulin levels was observed in diabetic women (3.14 ± 1.33) and in those co-infected with toxoplasmosis and diabetes (3.905 ± 1.51) as compared to the control group, at a significant level of P ≥ 0.05, and when studying the concentration of glucagon hormone, The insulin hormone levels of women with toxoplasmosis were not substantially different from those of women in the control group, according to the statistical analysis, although only the group infected with toxoplasmosis, diabetes, and diabetes mellitus showed a significant rise, which amounted to (104.00 ± 22.10, 89.33 ± 24.10) respectively compared to the control group (68.35 ± 13.46) at the level of significance ≤ 0.05.